Yes, it did take all of that, and a lot of fun and learning along the way!
I deeply appreciate all the effort that went into making this study possible.
Don’t miss the latest updates published @CellReports , with a spectacular tweetorial from the one and only @eportacangen !
It took 3 years, 4 rounds of reviews, 96 VISIUM samples, 10 cancer types, and 1 clinical trial, but it's finally out:
The spatial landscape of Cancer Hallmarks reveals patterns of tumor ecological dynamics and drug sensitivity
Here's what's new 👇
https://t.co/WMCyTWhVOX
🔥 Out now in @TrendsinBiotech!
A practical guide to spatial transcriptomics: lessons from >1000 samples 🧬🔬
From tissue prep to sequencing depth to platform choice — we distill 5 years of hard-earned experience into one field guide.
https://t.co/H8niwUNDC7
🚨 New preprint! 🚨
Cancer is not just mutated cells. It’s an ecosystem in motion.
We introduce Spatiotemporal Hallmark Ecosystems (SHEs) — a new framework to understand tumour evolution.
👉 https://t.co/UsrDjgwJhs
#Cancer biomarkers are more than a “what”—they can be a “where,” too. Read our new blog showcasing the DUTRENEO trial preprint, where researchers ID’d spatial biomarkers associated with #bladdercancer treatment response using the Visium platform. Read now! https://t.co/RmPYep8vFC
The scope and scale of this work is nothing short of breathtaking. All we can say is congratulations @eportacangen, and that your work and approach is demonstrating just how spatial bio is making a brighter future for clinical and drug discovery work. Well done!
Want to take your mind off the whole NIH-indirect costs drama? Interested in spatial transcriptomics, cancer, clinical research, or immunotherapy biomarkers?
Then this preprint and tweetorial are for you!
👇👇👇👇👇👇
https://t.co/FOQw8Bijis
The preprint with DUTRENEO results is out!
Beautiful trial design (thx @drenriquegrande and Paco Real!) testing TIS in the neoadjuvant setting for bladder cancer
+ A LOT of spatial data and analyses from @MustaphaSibai@DanielaGrases and yours truly
https://t.co/FOQw8Bijis
Edu is a great postdoc supervisor, and the group he leads consists of exceptionally smart and kind humans. Don't take my word for it, just come join us!
❗️🔬 Researchers led by @eportacangen reveal that tumour growth depends on position, not just cell types
➡️ By analyzing 63 tumour samples, they revealed that cancer hallmarks—key traits driving malignancy—are spatially organized in patterns
Read more👉 https://t.co/Akz1QcFlmC
Thank you for your kind words and thoughtful insights! The integration of spatial biology and tumor ecology indeed has the potential to reshape therapeutic strategies. By understanding the microenvironment and its interaction with tumors, we aim to refine drug selection and improve patient outcomes. Practical applications could include more precise biomarker-driven therapies and enhanced prediction of treatment responses. More to come shortly from the #DUTRENEO trial
The spatial landscape of cancer hallmarks reveals patterns of tumor ecological dynamics and drug sensitivity: Cell Reports https://t.co/H0UDVw1wYB
@BatlleLab@CNIOStopCancer@OncoAlert@CellReports
Congratulations 👏🏼👏🏼👏🏼!
It's not everyday you get to see one of your favourite preprints published.
I was still sharing the preprint results in my teaching on Friday.
Can't wait to dive into the final version of this amazing work 🙏🏾.
Thrilled to introduce our Cell Reports @cellreports
article, showing how the iconic '#Hallmarks of #Cancer' are located in the space of real human primary tumors. A team effort co-led by Eduard Porta @eportacangen , Matthew H. Bailey, and yours truly. #SpatialBiology#Visium
https://t.co/mmPZlXtBjl
Last week I had a wonderful time at the #SpatialOmics24 conferences in Ghent, with 2 days full of inspiring talks and mind-blowing advancements in the field of spatial biology and technologies. Also very thankful to the organizers for the oppurtunity to present our latest work.
And it's posted!
Comparison of spatial transcriptomics technologies across six cancer types
VISIUM + CytAssist + CosMx + Xenium + CytAssist protein
On serial sections from 6 human tumors
Tweetorial coming tomorrow
https://t.co/l0au9m085f
First set of Bladder Cancer samples from a Spanish clinical trial, processed with Xenium technology. Looking for spatial predictors of therapy response! @eportacangen@10xGenomics@MustaphaSibai@CarrerasIJC
Congrats Aymara and Paula!
Beautiful paper integrating single-cell and spatial transcriptomics to understand the effects of aging in the human myometrium
From our end, @DanielaGrases did all the spatial data and @mustaphasibai helped with the analyses
https://t.co/FwpkQAkvWa